Publications

5891 Results

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel

Authors
MJ Edelman;JI Clark;K Chansky;K Albain;N Bhoopalam;GR Weiss;JK Giguere;K Kelly;J Crowley;DR Gandara
Journal / Conference
Clinical Cancer Research 10:5022-5026
Year
2004
Research Committee(s)
Lung
Study Number(s)
S9806

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in Southwest Oncology Group chemotherapy trials

Authors
BGM Durie;J Jacobson;B Barlogie;J Crowley
Journal / Conference
Journal of Clinical Oncology 22(10):1857-1863
Year
2004
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30, SWOG-8624, SWOG-9028, SWOG-9210

SWOG 0101: Evaluation of gemcitabine and irinotecan in esophageal cancer

Authors
SK Williamson;S McCoy;JL Abbruzzese
Journal / Conference
American Society of Clinical Oncology Gastrointestinal Cancers Symposium #25
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
S0101

A phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study

Authors
RP Whitehead;J Moon;SS McCachren;EM Hersh;W Samlowski;JT Beck;NS Tchekmedyian;VK Sondak
Journal / Conference
Cancer 100(8):1699-1704
Year
2004
Research Committee(s)
Melanoma
Study Number(s)
S9804

Quality of Life (QOL) and pain in advanced stage prostate cancer: impact of missing data on evaluating palliation in SWOG 9916

Authors
DL Berry;CM Moinpour;C Jiang;LV Vinson;PN Lara;S Lanier;ME Taplin;PA Burch;DP Petrylak;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 23:400, (#4579)
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
S9916

Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): data from Southwest Oncology Group Study S9916

Authors
ED Crawford;DK Pauler;CM Tangen;MHA Hussain;EJ Small;ME Taplin;PA Burch;GF Greene;PN Lara Jr;DP Petrylak
Journal / Conference
Proc of the American Society of Clinical Oncology 23:382 (#4505)
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
S9916

SWOG 99-16: randomized phase III trial of docetaxel (D)/estramustine (E) versus mitoxantrone (M)/prednisone (p) in men with androgen-independent prostate cancer (AIPCA)

Authors
DP Petrylak;C Tangen;M Hussain;PN Lara;J Jones;M Talpin;P Burch;G Greene;E Small;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 23:2 (#3)
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
S9916

Significant impact of HLA class I allele expression on outcome in melanoma patients treated with an allogeneic melanoma cell lysate vaccine. Final analysis of SWOG-9035.

Authors
VK Sondak;J Sosman;JM Unger;PY Liu;J Thompson;R Tuthill;R Kempf;L Flaherty
Journal / Conference
Proc of the American Society of Clinical Oncology 23:707 (#7501)
Year
2004
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Predictors of vitality (energy/fatigue) in early stage hodgkin's disease (HD): results from Southwest Oncology Group (SWOG) study 9133

Authors
PA Ganz;CM Moinpour;S McCoy;DK Pauler;OW Press;RI Fisher
Journal / Conference
Proc of the American Society of Clinical Oncology 23:567 (#6546)
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9208

EGFr dinucleotide repeat polymorphism in non-small cell lung cancer

Authors
S Dubey;J Miller;P Stephenson;SM Keller;DH Johnson;JH Schiller;JM Kolesar
Journal / Conference
Proc of the American Society of Clincial Oncology 23:852 (#9585)
Year
2004
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)